News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Collegium Pharmaceutical, Inc. Expands its Management Team to Support Continued Development of DETERx® Tamper-Resistant, Extended-Release Opioid Program



7/9/2012 10:51:32 AM

CUMBERLAND, R.I.--(BUSINESS WIRE)--Collegium Pharmaceutical, Inc., a specialty pharmaceutical company focused on the development of innovative treatments for chronic pain, is pleased to announce the addition of three key members to its management team. Ernest A. Kopecky, PhD, MBA has joined the Company and will lead the clinical development team as Vice President, Clinical Development and Head, Neuroscience Therapeutic Area. In addition, Kathleen Findlen has joined the Company as Director of Clinical Operations and Stephen Mayock will lead the analytical team as Director of Analytical Development and Quality Control.

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES